ABSTRACT The sequential events of the properdin system were analyzed. Properdin-depleted serum allows the formation of a Factor B-and D-dependent C3 convertase. This enzyme, called the properdin-receptor-forming enzyme, was shown to utilize a novel serum component, the initiating factor. The protein is a a-globulin in recursor form and is distinct from immunoglobulins. The function of the enzyme is to deposit C3b on the surface of activator particles. Apparently doublets of C3b are required for the formation of the properdin-activating principle. It consists of a complex containing surface-bound C3b and activated Factor B. Properdin precursor is activated by binding to this complex without detectable change in molecular weight. The transition of properdin precursor to activated properdin is probably caused by a conformational change. The complex, consisting of bound C3b, properdin, and activated Factor B, represents the enzyme that acts on C5, thereby initiating self-assembly of the membrane attack system. Native C3 is not needed for the function of the enzyme. It is disassembled by soluble C3 or C3b and its formation is under the control of the properdinreceptor-destroying enzyme, which may be identical with the C3b inactivator.
More thin 20 years ago Pillemer and his associates approached the problem of natural resistance to infections on the molecular level. A novel serum protein, termed properdin, was envisaged to cooperate with hydrazine-sensitive "Factor A" and heat-labile "Factor B" in the activation of complement resulting in natural resistance against certain viruses and bacteria (1, 2) .
Today we recognize the properdin system or the alternative pathway of complement activation to consist of five components: properdin (P) (3), the third component of complement, C3 (Factor A) (4, 5) , proactivator (Factor B) (6) , proactivator convertase (Factor D) (5, 7, 8) and the initiating factor (Factor I or IF) (9) , which will be introduced in this communication as a heretofore unknown component.
Four On the basis of a large body of experimental evidence, which will be fully documented elsewhere (9) (10) (11) , we wish to propose a comprehensive molecular concept of the properdin pathway. In brief, the dynamics of the pathway involve assembly of the properdin-receptor-forming enzyme (PRFE) as a consequence of activation of the initiating factor, assembly of the properdin-activating principle, and formation of the properdin-dependent convertase which catalyzes opsonization and activation of the membrane attack system.
Initiation of the properdin pathway without properdin (P) In exploring the possible role of P in the initiation of the pathway, serum was immunochemically depleted of P. In addition, to block the classical pathway, C4 was removed from the same serum. Treatment of the depleted serum with yeast cell walls (zymosan) resulted in uptake of C3 by the particles. This uptake was dependent upon the presence of Factors B and D and magnesium ions and, as will be described below, on Factor I (Table 1) . Treatment for 60 min at 370 caused 15-22% consumption of serum C3. In absence of zymosan, B, or D, CS consumption did not exceed 7%. This finding pointed out the existence of a C3 convertase that utilized B and D but not P, and that deposited CS on particles, probably in the form of C3b (9). Our observations preclude a role of properdin in the initiation of the pathway and lend no support to the concept proposed by Fearon and Austen according to which properdin is required for formation of the initial CS convertase (12) .
Recognition of an initiating factor distinct from properdin Another clue for the existence of a P-independent C3 convertase was derived from work on nephritic factor (NF), which is an unusual serum protein occurring in certain nephritides (13) . NF associates with B. D, CS, and Mg to form a soluble C3 convertase which is functionally indistinguishable from its P-dependent counterpart (14) .
It was hypothesized that an NF-analogue is present in normal serum in precursor form and constitutes an essential component of the initial CS convertase. An antiserum to NF was utilized to explore normal serum for the presence of an NF-analogue. Anti-NF-treated serum failed to sustain C3 consumption upon prolonged incubation with zymosan. (14, 16) . That it is critically involved in the activation of properdin will be described below. The enzyme responsible for the formation of the receptor, that is, for the initial deposition of C3b on activating surfaces, is the IF-C3 convertase (9) . The enzyme is generated from activated IF, B, D, native C3, and Mg. In analogy to the previously described NF-C3 convertase (14) (11) . Using P in radiolabeled form, it was found that it was bound and activated by the complex consisting of the properdin receptor and activated Factor B (S-C3b,B, where S denotes a surface site) (10) . The reaction proceeds in EDTA and therefore does not require conditions allowing continued formation of S-C3b,B (Table 2 ). This complex is identical with the previously described C3b-dependent C3 convertase which is also known as the feedback enzyme (5, 18) . Although the complex has an enzymatic function, present evidence suggests that P binding and activation is a non-enzymatic process. For instance, no turnover of P was detected. No activated or irreversibly inactivated P accumulated in the fluid phase. The loss of precursor from the fluid phase was totally accounted for by the amount of specifically bound P. Utilizing differentially radiolabeled B and P and C3b-bearing erythrocytes (EC3b), maximally one molecule of P was bound per molecule of B. A further characteristic of the properdin-activating principle is that only some of the bound C3b molecules can serve to form the activating principle. Approximately C3b . The site S-C3b,P can reform the complex S-C3b,P,B upon addition of B, D, and Mg. These and the previously mentioned observations demonstrate a functional difference between P and P. In exploring the chemical basis for the P-P transition, the subunit molecular weights of both forms were determined. Since the molecular weights were indistinguishable, we propose that the P-P transition is a nonenzymatic process that, in all probability, involves a critical conformational change of the properdin molecule (11) .
Two forms of P may be distinguished. The physiological form of P is properdin bound to the properdin receptor through the above-described reaction. Upon dissociation of bound P it appears to revert largely to the precursor state. The second form of P has been obtained in the laboratory from the serum euglobulin fraction at low pH. The activity of this form may be due to the purification procedure because, under physiological conditions, transition of P to P in solution has so far not been observed. It is conceivable, however, that soluble P arises by spontaneous dissociation from S-C3b,P or by enzymatic destruction of the properdin receptor.
Assembly and function of C3 and C5 convertase In the classical pathway, C3 convertase constitutes a bimolecular complex of fragments of C2 and C4 (C4b,2a) (19) . Incorporation of C3b into this complex gives rise to C5 convertase activity (20) . The catalytic site of both enzymes resides in the C2a subunit (21) . By (24) . In fact, Fearon and Austen have since demonstrated retardation of decay of C3b,B by P (16) .
The investigation of the precise subunit composition of the P-dependent convertases was greatly aided by the introduction by Fearon et al. of the erythrocyte-bound enzymes (22) . Using this experimental technique we were able to de- fine the essential structure of the alternative C5 convertase (10). Stoichiometric measurements using radiolabeled components revealed a probable composition of one B molecule per one P molecule per two C3b molecules. The enzyme acts on C3 and C5, exhibiting a higher turnover for CS than for C5. Its direct action on C5, in absence of C3, was demonstrated by the formation of stable C5,6,7 sites on the surface of the enzyme-carrying erythrocytes upon incubation with highly purified C5, C6, and C7 (Table 3) . It is of physiological importance that the enzyme may undergo reverse assembly. Following dissociation of B. the residual complex S-C3bP can reincorporate B and regain full enzymatic activity. EC3b may bind soluble P, forming EC3b,P (Table 2) Regulation Three distinct modes of control have become apparent in the course of this study. The enzymes decay spontaneously at 370, the IF-and P-dependent convertases with a half-life ofapproximately 15 min and 2 min for the non-stabilized C3bB. Decay is accompanied by dissociation of inactive B.
The activity of the P-dependent convertase was found to be inhibited by the product C3b, but not by C5b. The C3 fragment effects inhibition by disassembly of the active enzyme with release of inactive B. Native CS has the same ap- parent effect. The IF-dependent enzyme is, in all probability, similarly regulated by soluble C3b. The third mode of control involves fragmentation of the properdin receptor C3b by a serum enzyme. The enzyme acts on bound C3b as well as on the bound C3b,P complex. In the former case it destroys the properdin receptor function and in the latter situation it releases properdin, probably in association with a CS fragment. Action of the enzyme on the bound C3b,P complex could explain the appearance of soluble P, provided this form of properdin does occur under physiological conditions. It is probable that the enzyme cleaves C3b into C3c and CMd (25) and that it represents the known C3b inactivator (26) . Since its identity has not been established, it is here referred to as the properdin-receptordestroying enzyme (PRDE). In contradistinction to its effect on S-C3b and S-C3b,P, PRDE has little or no effect on S-C3bh and S-C3b,P,B, suggesting that the susceptible region in C3b is protected within these complexes (Table 4 ). Synopsis Fig. 1 depicts a schematic representation of the proposed concept. The initial events occur on the surface of the activating particle. It is envisioned that the precursor of IF establishes contact with the activating particle (SI) and then interacts with B, D, and native C3 to generate the P receptor-forming enzyme (PRFE), which is the initial C3 convertase.* PRFE is a low magnitude enzyme which is limited in its action by spontaneous decay and disassembly through soluble C3b. PRFE deposits C3b at sites (S2) in the vicinity of the enzyme. Properdin receptor function resides in at least two critically oriented and closely spaced C3b molecules.
Binding of activated B to the receptor results in generation of the properdin-activating principle, C3b,B. The complex, which is identical with the feedback enzyme, has C3 and C5 convertase activity and is exceedingly labile. Upon collision of native P with the complex, P undergoes a transition to its bound form, P. P confers an increased degree of stability on C3b,B converting it to the C3b,P,B enzyme. The P-enzyme effects activation of C5 and self-assembly of the membrane attack complex C5b-9 (28). CS does not participate in this enzymatic reaction. When present, C3 is turned over and the enzyme is disassembled at a rate greater than that characteristic for its spontaneous decay. Reverse assembly of the enzyme may commence with uptake of P by S2-C3b and is completed after incorporation of B into the complex. Action of the P-receptor-destroying enzyme (PRDE) on S2-C3b abrogates-its receptor function, and action of the enzyme on S2-MCb,P releases properdin posssibly in association with CSc. Although IF and P are subunits of closely related enzymes, they differ with respect to their essential functions. IF probably serves as the recognition factor of the properdin system, while P is limited to interaction with the C3b,B complex. Whereas IF fulfills the role of the nucleus of an assembling enzyme, P functions as modulator of an already assembled enzyme. IF exhibits affinity primarily for B and not for C3 or C3b. P exhibits affinity primarily for C3 or C3b and not for B. Three components, C3, B, and D, are operative at all stages of the pathway and B contains the essential catalytic site of all C3 and C5 convertases.
Properdin itself does not play the central role in the pathway it had once been assigned. It is recruited late in the sequence rather than early as was previously assumed. It greatly augments the cytolytic efficiency of the pathway, but its function is a nonessential one compared to that of the other components of the properdin system. * Until larger quantities of highly purified initiating factor precursor become available, the participation of an accessory factor in initiation cannot be precluded (27) . Immunology: Medicus et al. C5,6,7,8 ,9- 
